4//SEC Filing
Welch Stephen Andrew 4
Accession 0001104659-25-110627
CIK 0001567892other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 8:00 PM ET
Size
5.9 KB
Accession
0001104659-25-110627
Insider Transaction Report
Form 4
Welch Stephen Andrew
EVP & Head of Spec Generics
Transactions
- Disposition to Issuer
Restricted Stock Units
2025-11-10+43,771→ 0 total→ Ordinary Shares (43,771 underlying)
Footnotes (1)
- [F1]These restricted units were cancelled in connection with the separation of Par Health, Inc. ("Par Health") from the Issuer in exchange for a number of restricted units of Par Health calculated pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.
Documents
Issuer
Keenova Therapeutics plc
CIK 0001567892
Entity typeother
Related Parties
1- filerCIK 0001944355
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 8:00 PM ET
- Size
- 5.9 KB